Viive M. Howell

Sydney, NSW 2006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.

CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.

Journal: Cancers

Published: January 15, 2024

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma.

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma.

Journal: Cancers

Published: June 24, 2022

The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer.

The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer.

Journal: Cancers

Published: May 31, 2022

Differential effects of radiation fractionation regimens on glioblastoma.

Differential effects of radiation fractionation regimens on glioblastoma.

Journal: Radiation oncology (London, England)

Published: August 12, 2021

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: July 14, 2021

Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis.

Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective Analysis.

Journal: Journal of clinical medicine

Published: April 18, 2021

Are In Vitro Human Blood-Brain-Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?

Are In Vitro Human Blood-Brain-Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?

Journal: Cancers

Published: February 08, 2021

Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma.

Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma.

Journal: Frontiers in oncology

Published: November 24, 2020

Overlooked potential of positrons in cancer therapy.

Overlooked potential of positrons in cancer therapy.

Journal: Scientific reports

Published: October 13, 2020

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches.

Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches.

Journal: International journal of molecular sciences

Published: June 09, 2020

Anti-epidermal growth factor receptor therapy for glioblastoma in adults.

Anti-epidermal growth factor receptor therapy for glioblastoma in adults.

Journal: The Cochrane database of systematic reviews

Published: May 13, 2020

ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling.

ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling.

Journal: The oncologist

Published: February 02, 2020

Showing 1-12 of 57

Last Updated: 09/26/2026